William Kevin Kelly, DO, Quoted in Reuters
William Kevin Kelly, DO, professor of medical oncology and urology at Thomas Jefferson University, was quoted in a July 14 Reuters story. The article is on the FDA panel's decision on the use of the experimental drug Adcetris for Hodgkin's lymphoma and anaplastic large cell lymphoma.
"It's an excellent drug, but we need more experience with it overall," said Kelly.
Read "US panel backs stricter blood cancer drug label" to learn more.
The story was also picked up by Fox News and Yahoo! News.
Publication: Reuters
Published: 7/14/2011